CWH43 Inhibitors
CWH43 inhibitors are a class of chemical compounds specifically designed to thwart the activity of the CWH43 protein. CWH43, encoded by the CWH43 gene, is a protein that plays a crucial role in various cellular processes, including lipid metabolism and cell membrane organization. The inhibitors targeting this protein are characterized by their ability to bind to the active or allosteric sites of CWH43, which can lead to conformational changes that ultimately reduce or abolish the protein's functional activity. These inhibitors are typically small molecules that can permeate cell membranes to engage with CWH43 within the cellular milieu. By impeding the normal function of CWH43, these inhibitors can influence the homeostasis and dynamics of cellular membranes, particularly affecting the distribution and abundance of certain lipid species.
The action of CWH43 inhibitors is complex and involves a cascade of cellular changes that extend beyond the direct interaction with the protein. Once the active site of CWH43 is occupied by an inhibitor, the enzymatic activity associated with the protein is diminished, leading to downstream effects on lipid signaling and membrane structure. These changes can alter the physical properties of membranes, such as fluidity and curvature, which are essential for numerous cell functions including vesicle formation, cell division, and intracellular trafficking. The specificity of CWH43 inhibitors ensures that the impact is restricted to pathways directly related to the function of CWH43, thus allowing for a targeted approach to manipulate cellular lipid composition and distribution. This specificity is critical as it ensures the inhibitors do not indiscriminately disrupt cellular functions but rather exert their effects through precise molecular interactions with CWH43.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin specifically binds to FKBP12 and the resulting complex inhibits mTOR, a downstream kinase in the PI3K/AKT pathway. As CWH43 is involved in the regulation of cell growth and proliferation, inhibition of mTOR results in reduced protein synthesis and cell cycle arrest, thereby decreasing the functional activity of CWH43. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a potent inhibitor of phosphoinositide 3-kinases (PI3K), which blocks the PI3K/AKT signaling pathway. Since CWH43 activity is associated with this pathway through its role in cell growth and survival, inhibition by LY294002 leads to a decrease in AKT phosphorylation and subsequent reduction in CWH43 activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor that irreversibly inhibits the enzyme, leading to the downregulation of the PI3K/AKT pathway. The decreased signaling through this pathway results in a reduction of CWH43 activity due to its reliance on PI3K for proper function. | ||||||
Triciribine | 35943-35-2 | sc-200661 sc-200661A | 1 mg 5 mg | $104.00 $141.00 | 14 | |
Triciribine specifically inhibits the phosphorylation and activation of AKT, which is downstream of PI3K. By preventing AKT activation, triciribine indirectly leads to the decreased activity of CWH43, which is implicated in the same signaling pathway. | ||||||
Perifosine | 157716-52-4 | sc-364571 sc-364571A | 5 mg 10 mg | $188.00 $327.00 | 1 | |
Perifosine is a synthetic alkylphospholipid that acts as an AKT inhibitor. By inhibiting AKT, it interferes with the downstream signaling of the PI3K/AKT pathway, which is necessary for CWH43 functional activity, leading to its inhibition. | ||||||
MK-2206 dihydrochloride | 1032350-13-2 | sc-364537 sc-364537A | 5 mg 10 mg | $182.00 $332.00 | 67 | |
MK-2206 is a highly selective inhibitor of AKT. This compound allosterically inhibits AKT phosphorylation, resulting in reduced signaling through the PI3K/AKT pathway, which is critical for CWH43 activity. | ||||||
GDC-0941 | 957054-30-7 | sc-364498 sc-364498A | 5 mg 10 mg | $188.00 $199.00 | 2 | |
GDC-0941 is a potent and selective oral inhibitor of PI3K. By selectively targeting PI3K, it reduces the activation of AKT and subsequently decreases the functional activity of CWH43. | ||||||
ZSTK 474 | 475110-96-4 | sc-475495 | 5 mg | $75.00 | ||
ZSTK474 is a selective PI3K inhibitor, which suppresses the phosphorylation of AKT, leading to a reduction in the PI3K/AKT pathway signaling and therefore decreasing the functional activity of CWH43. | ||||||
Everolimus | 159351-69-6 | sc-218452 sc-218452A | 5 mg 50 mg | $131.00 $651.00 | 7 | |
Everolimus is an mTOR inhibitor similar to rapamycin. It binds to FKBP12 and inhibits mTOR activity, leading to a decrease in the activity of proteins like CWH43 that are downstream of the mTOR pathway. | ||||||